David H. Crean, Ph.D.

David H. Crean, Ph.D.

Chief Business OfficeratMedicinova· In proxies 2024–2025

Pay in FY2025+21% from the year before · Medicinova stock -37.6% the same year

David H. Crean, Ph.D. was paid $120.0K in FY2025 (Dec), up 21%. Medicinova stock fell 37.6% that year.

Pay$100 in the stock at the end of FY23 → $87
Pay is from the Summary Compensation Table of each Medicinova proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. MedicinovaPublic company · 2 yr
    • Chief Business Officer2024 – Present · 2 yrStock in role +7%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?